Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
Delayed Xetra  -  11:35:25 2023-02-03 am EST
19.00 EUR   -1.68%
01/25Biopharma, Tech Stocks Lead European Equities Slightly Lower
MT
01/24Pharma Stocks Weigh Down European Equities in Tuesday Trading
MT
01/19Pharma Stocks Weigh Down European Equities in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Climb Sharply Higher in Monday Trading

09/12/2022 | 11:03am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -4.05% 1.66 Delayed Quote.18.49%
AKARI THERAPEUTICS, PLC 4.62% 0.51 Delayed Quote.3.75%
AUTOLUS THERAPEUTICS PLC -1.93% 2.03 Delayed Quote.6.84%
BARCLAYS PLC 0.13% 188.64 Delayed Quote.19.00%
CREDIT SUISSE GROUP AG -1.07% 3.316 Delayed Quote.19.97%
CRH PLC 0.11% 3942 Delayed Quote.19.49%
ERYTECH PHARMA S.A. 2.33% 1.14 Real-time Quote.210.80%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.42% 35.61 Delayed Quote.16.49%
FRESENIUS SE & CO. KGAA -0.44% 27.11 Delayed Quote.3.28%
GENFIT 5.42% 4.2 Real-time Quote.5.85%
ING GROEP N.V. -0.82% 12.6 Real-time Quote.10.64%
MORPHOSYS AG -1.68% 19 Delayed Quote.43.83%
SEQUANS COMMUNICATIONS S.A. 0.62% 3.24 Delayed Quote.-3.01%
VOXELJET AG -3.88% 2.48 Delayed Quote.12.17%
WPP PLC 1.57% 1033.5 Delayed Quote.26.01%
All news about MORPHOSYS AG
01/25Biopharma, Tech Stocks Lead European Equities Slightly Lower
MT
01/24Pharma Stocks Weigh Down European Equities in Tuesday Trading
MT
01/19Pharma Stocks Weigh Down European Equities in Thursday Trading
MT
01/13European Equities Rise in Friday Trading, ADRs End Week Up 2%
MT
01/11Transcript : MorphoSys AG Presents at 41st Annual J.P. Morgan Healthcare Conf..
CI
01/11Pharma Stocks Pull European Equities Lower in Wednesday Trading
MT
01/09MorphoSys Expects Topline Data From Phase 3 Trial of Bone Marrow Cancer Therapy in Earl..
MT
01/09MorphoSys AG Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in ..
CI
01/09Morphosys Ag : MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofib..
EQ
01/06Morgan Stanley downgrades Morphosys to 'Underweight'.
DP
More news
Analyst Recommendations on MORPHOSYS AG
More recommendations
Financials
Sales 2022 247 M 268 M 268 M
Net income 2022 -442 M -479 M -479 M
Net Debt 2022 146 M 159 M 159 M
P/E ratio 2022 -1,52x
Yield 2022 -
Capitalization 649 M 704 M 704 M
EV / Sales 2022 3,22x
EV / Sales 2023 2,19x
Nbr of Employees 627
Free-Float 98,1%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Last Close Price 19,00 €
Average target price 23,44 €
Spread / Average Target 23,4%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Tim Demuth Chief Research & Development Officer
Krisja Vermeylen Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG43.83%704
MODERNA, INC.-1.82%66 559
LONZA GROUP AG21.92%44 368
IQVIA HOLDINGS INC.15.76%44 054
ALNYLAM PHARMACEUTICALS, INC.-3.32%28 711
SEAGEN INC.7.38%25 622